Cook County preparing for $211M budget deficit for 2026
County Board President Toni Preckwinkle, who has been able to boast budgets free of taxes, fees or layoffs for the last several years, told reporters at a Tuesday briefing that the 2026 projection is the most 'problematic,' and cautioned that 'this is our best guess.'
The county is expecting a general fund shortfall of $102.6 million, thanks mostly to higher wages and fringe benefits when its current contracts with union employees expire. Its health fund, meanwhile, is projecting a $108.8 million deficit thanks to a significant drop in patient revenues.
Among the biggest long-term potential threats: how Congress ultimately decides the fate of Medicaid, which has helped prop up the finances of Cook County Health; and various federal grants President Donald Trump targeted with an avalanche of executive orders.
The budget proposal that passed the U.S. House — but not yet the full Senate — cuts Medicaid by at least $625 billion over the next decade. As it stands, most of the biggest impacts would not hit until the county's 2027 budget, but health leaders say they are planning their response now.
New proposed work requirements and more frequent checks to determine whether people qualify for Medicaid would begin at the very end of 2026, and cost an estimated $88 million in patient fees, according to county estimates. The beginning of a provision meant to curtail the Medicaid program helping immigrant seniors would start in October 2027, according to the county. Ending that Health Benefits for Immigrant Seniors program would mean a $50 million drop in patient fee revenue for the county.
The state is already sunsetting its health care program for immigrant adults, which is expected to cost the county $5.5 million in net patient service revenues through the end of this year.
Cuts to covered health care typically means the CCH, a safety-net hospital, ends up providing tens of millions of dollars of uncompensated care to people without insurance at its emergency rooms and clinics.
CCH plans to enroll patients previously covered by the state's immigrant adult program in its CareLink program, which covers 100% of primary and specialty care, hospital care and imaging costs for the next year, a spokeswoman said.
Even without federal concerns, the county is expecting other costs to rise, since several union contracts expire in November, opening up bargaining countywide. During the last round of bargaining, the county granted retroactive 3.5% pay increases dating back to 2021 and a 5% raise in 2025. And a pending lawsuit from road builders over the county's spending of 'lockbox' money on public safety offices could affect the bottom line of the general fund.
Last year, the projected shortfall mostly took care of itself by the time fall budget season rolled around. Revenues were higher than expected, closing most of the $218 million projected gap.
The county is expecting some cushion. Its main general fund is projected to end this year with a $145 million surplus, thanks to a dip in payroll costs and better-than-expected sales tax revenues thanks to a closed loophole involving online sales.
Preckwinkle's finance team policy is not to use that money to plug the next year's gap, but officials said they might use the money to keep paying for programs and positions at risk of being cut if federal grants end.
As federal pandemic aid dollars dwindle, Preckwinkle's team has also narrowed its list of programs it might extend after 2026, the county's deadline for spending its total $1 billion allocation.
It would cost about $100 million a year to keep 19 programs — ranging from lead pipe removal and brownfield remediation to violence prevention and medical debt relief — going. The county has set aside $166 million in a 'reserve' fund to help pay for those, meaning officials must either cut down on its offerings or find another $255 million to keep them running.
Preckwinkle will make her budget proposal on Oct. 9, with a final vote scheduled for Nov. 20.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
26 minutes ago
- Time Business News
Navigating the IOP Landscape: A Step-by-Step Startup Guide
Launching an Intensive Outpatient Program in behavioral health is an opportunity to combine strong clinical impact with a scalable business model. It begins with understanding your community's needs, defining your target population, and shaping a program that fills an actual gap in care. This requires market research, competitor analysis, and conversations with referral sources to design group schedules, specialty tracks, and service hours that truly fit the lives of those you aim to serve. Creating an intensive outpatient program begins with identifying the specific needs of your target population and developing a service model that delivers measurable results. Careful planning ensures the program offers flexible scheduling while maintaining clinical rigor. Securing qualified staff, establishing evidence-based treatment protocols, and complying with local and federal regulations are vital steps. Knowing how to start an IOP program means also addressing insurance credentialing, community outreach, and outcome tracking to demonstrate value. When designed thoughtfully, such programs provide the structure and support clients need to recover while continuing their daily responsibilities, fostering long-term healing and stability. Once your concept is clear, choosing a compliant, accessible location is essential. Your site should be zoned appropriately for healthcare, designed to ensure privacy, and equipped with multiple group spaces, a private intake area, and technology-ready rooms for telehealth. From the start, align your licensing and accreditation plan with state requirements—such as DHCS Licensing for Behavioral Health in California—and aim for CARF or Joint Commission accreditation to strengthen both credibility and payer relationships. Your clinical program should follow evidence-based practices and offer a structured mix of group therapy, individual sessions, family involvement, and psychiatric care. Clearly define admission criteria, safety protocols, and step-up or step-down care pathways. A strong staffing plan is crucial, with leadership, licensed clinicians, case managers, and prescribers all in place, and payer credentialing for each provider completed early to avoid delays. Supporting this team with an EHR designed for behavioral health, HIPAA-compliant telehealth tools, and robust documentation workflows will set the tone for smooth operations. Financial planning is equally important, with a realistic budget that covers startup expenses, operating reserves, and the inevitable collections lag in insurance-based care. Develop a payer mix strategy that blends commercial insurance, Medicaid where viable, and cash pay options, while maintaining rigorous denial management practices. Ethical marketing—built on strong referral networks, local SEO, and a responsive intake process—will help admissions grow steadily without overreliance on advertising. From referral to discharge, every step in the client journey should be mapped and intentional. Intake processes, treatment planning, progress tracking, and alumni engagement must be consistent and streamlined. Measurement-based care using tools like the PHQ-9 or GAD-7 not only improves clinical quality but also supports payer negotiations and continuous quality improvement. Alongside this, strict adherence to HIPAA, 42 CFR Part 2, and risk management protocols ensures client trust and protects your business from compliance issues. Establishing a behavioral health program begins with a clear framework for quality, safety, and accountability. From securing the right facility to hiring qualified staff, every step must align with industry regulations. A crucial part of this process is understanding and obtaining DHCS licensing for behavioral health, which ensures that your services meet state standards for treatment delivery and patient protection. This involves preparing documentation, passing inspections, and adhering to ongoing reporting requirements. Compliance not only protects your organization legally but also strengthens trust with clients and payers, setting the stage for long-term sustainability in the behavioral health field. Launching an IOP successfully means starting small, testing workflows, collecting feedback, and refining before scaling. Once operations are stable, you can expand to additional tracks, services, or locations, supported by standardized policies, clinical curricula, and data-driven decision-making. For those exploring how to start an addiction treatment center through a broader network, a well-run IOP can become both a powerful standalone business and a strategic building block for future growth. TIME BUSINESS NEWS
Yahoo
5 hours ago
- Yahoo
FDA may revoke Pfizer COVID-19 shot for young, healthy children.
The Food and Drug Administration may revoke authorization for Pfizer's COVID-19 vaccine for healthy children under age 5, the pharmaceutical company confirmed, which would limit parents' vaccine options ahead of the winter respiratory virus season. The possibility comes several months after President Donald Trump's Department of Health and Human Services began placing limits on COVID-19 vaccines. For the last four years, updated COVID-19 vaccines have been made available in the fall for most Americans before the cold sets in. The federal agency told Pfizer that it might not renew the emergency use authorization, or EUA, for the Pfizer-BioNTech COVID-19 vaccine Comirnaty for children ages 6 months through 4 years, according to a statement sent to USA TODAY. 'We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season,' a company spokesperson said. 'It is important to note that these deliberations are not related to the safety and efficacy of the vaccine, which continues to demonstrate a favorable profile.' HHS spokesperson Andrew Nixon declined to predict what the agency might do. 'We do not comment on potential, future regulatory changes,' Nixon said. 'Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation.' In July, Moderna received full FDA approval for its COVID-19 vaccine for children 6 months to 11 years old who are at increased risk of contracting COVID-19. The vaccine, Spikevax, is expected to be available for eligible populations in the 2025-26 respiratory virus season. The Centers for Disease Control and Prevention still recommends older patients get vaccinated against COVID-19, as well as people whose immune systems have been weakened by illness or medical treatments such as chemotherapy. But if Pfizer loses its EUA, parents won't have the option to vaccinate their healthy young children. HHS Secretary Robert F. Kennedy Jr. has long sown doubt about a wide range of vaccines, while saying parents should be able to choose which vaccines their children should get. In late May, he announced that the COVID-19 vaccine for healthy children and healthy pregnant women was removed from the Centers for Disease Control and Prevention's immunization schedule. 'There's no evidence healthy kids need it today," Dr. Marty Makary, FDA commissioner, said in the May 27 video announcement posted to X. The American Academy of Pediatrics pushed back, saying at the time that the removal 'ignores independent medical experts and leaves children at risk.' Ending access to vaccination for healthy young children would strip families of choice, said Dr. Sean O'Leary, chair of the academy's committee on infectious diseases, in a May statement. 'Those who want to vaccinate may no longer be able to, as the implications for insurance coverage and access remain unclear," he said. This article originally appeared on USA TODAY: FDA might revoke Pfizer COVID-19 shot for children
USA Today
5 hours ago
- USA Today
FDA may revoke Pfizer COVID-19 shot for young, healthy children.
Parents won't be able to vaccinate their healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization. The Food and Drug Administration may revoke authorization for Pfizer's COVID-19 vaccine for healthy children under age 5, the pharmaceutical company confirmed, which would limit parents' vaccine options ahead of the winter respiratory virus season. The possibility comes several months after President Donald Trump's Department of Health and Human Services began placing limits on COVID-19 vaccines. For the last four years, updated COVID-19 vaccines have been made available in the fall for most Americans before the cold sets in. The federal agency told Pfizer that it might not renew the emergency use authorization, or EUA, for the Pfizer-BioNTech COVID-19 vaccine Comirnaty for children ages 6 months through 4 years, according to a statement sent to USA TODAY. 'We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season,' a company spokesperson said. 'It is important to note that these deliberations are not related to the safety and efficacy of the vaccine, which continues to demonstrate a favorable profile.' HHS spokesperson Andrew Nixon declined to predict what the agency might do. 'We do not comment on potential, future regulatory changes,' Nixon said. 'Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation.' In July, Moderna received full FDA approval for its COVID-19 vaccine for children 6 months to 11 years old who are at increased risk of contracting COVID-19. The vaccine, Spikevax, is expected to be available for eligible populations in the 2025-26 respiratory virus season. The Centers for Disease Control and Prevention still recommends older patients get vaccinated against COVID-19, as well as people whose immune systems have been weakened by illness or medical treatments such as chemotherapy. But if Pfizer loses its EUA, parents won't have the option to vaccinate their healthy young children. HHS Secretary Robert F. Kennedy Jr. has long sown doubt about a wide range of vaccines, while saying parents should be able to choose which vaccines their children should get. In late May, he announced that the COVID-19 vaccine for healthy children and healthy pregnant women was removed from the Centers for Disease Control and Prevention's immunization schedule. 'There's no evidence healthy kids need it today," Dr. Marty Makary, FDA commissioner, said in the May 27 video announcement posted to X. The American Academy of Pediatrics pushed back, saying at the time that the removal 'ignores independent medical experts and leaves children at risk.' Ending access to vaccination for healthy young children would strip families of choice, said Dr. Sean O'Leary, chair of the academy's committee on infectious diseases, in a May statement. 'Those who want to vaccinate may no longer be able to, as the implications for insurance coverage and access remain unclear," he said.
